麝香保心丸治疗老年慢性充血性心力衰竭的疗效观察_West China Medical Journal

Authors：

 牛婵娟 , 刘平

秦皇岛市北戴河医院内科（河北秦皇岛，066100）;

Corresponding author：

Keywords：

麝香保心丸; 慢性充血性心力衰竭; C-反应蛋白; 老年患者

DOI：

10.7507/1002-0179.20140092

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

目的研究麝香保心丸治疗老年慢性心力衰竭的疗效观察及对C-反应蛋白（CRP）的影响。方法将2010年1月－2012年1月收治的62例患者随机分为治疗组及对照组，每组31例，两组均给予一般治疗及基础药物治疗，治疗组加用麝香保心丸。治疗30 d后检测心搏出量（SV）、左心室射血分数（LVEF）、左心室收缩末期容积指数（LVESVI）、左心室舒张末期容积指数（LVEDVI）及CRP，两组进行对照比较。结果两组患者各项指标较治疗前均显著改善，且治疗组大部分指标的改变显著高于对照组。结论麝香保心丸能降低心肌耗氧量，增强心肌收缩力，降低血清CRP浓度，减轻炎症反应，显著改善心衰症状。

Citation： 牛婵娟, 刘平. 麝香保心丸治疗老年慢性充血性心力衰竭的疗效观察. West China Medical Journal, 2014, 29(2): 303-304. doi: 10.7507/1002-0179.20140092 Copy

1.	王丽洁,罗心平,王涌,等.冠心病稳定性心绞痛患者长期应用麝香保心丸的临床耐受性与安全性评价[J].中国中西医结合杂志,2008,28(5):399-401.
2.	孙菁,周进祝.内科学[M].7版.北京:科学出版社,2003:298-299.
3.	Rapezzi C,Biagini E,Branzi A.Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes:the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology[J].Eur Heart J,2007,28(13):1598-1660.
4.	Lloyd-Jones DM,Liu K,Tian L,et al.Narrative review:assessment of C-reactive protein in risk prediction for cardiovascular disease[J].Ann Intern Med,2006,145(1):35-42.
5.	Arima H,Kubo M,Yonemoto K,et al.High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese:the Hisayama study[J].Arterioscler Thromb Vasc Biol,2008,28(7):1385-1391.
6.	Tao L,Gao E,Jiao X,et al.Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress[J].Circulation,2007,115(11):1408-1416.
7.	车贤达,钱琳艳,高瑞兰.麝香保心丸预防冠心病PCI术后再狭窄的临床疗效观察[J].中华中医药学刊,2008,26(4):765-766.
8.	梁铁军,赵小茜,王爱武,等.麝香保心丸治疗心律失常238例疗效分析[J].山东医药,2004,44(23):24-25.

1. 王丽洁,罗心平,王涌,等.冠心病稳定性心绞痛患者长期应用麝香保心丸的临床耐受性与安全性评价[J].中国中西医结合杂志,2008,28(5):399-401.
2. 孙菁,周进祝.内科学[M].7版.北京:科学出版社,2003:298-299.
3. Rapezzi C,Biagini E,Branzi A.Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes:the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology[J].Eur Heart J,2007,28(13):1598-1660.
4. Lloyd-Jones DM,Liu K,Tian L,et al.Narrative review:assessment of C-reactive protein in risk prediction for cardiovascular disease[J].Ann Intern Med,2006,145(1):35-42.
5. Arima H,Kubo M,Yonemoto K,et al.High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese:the Hisayama study[J].Arterioscler Thromb Vasc Biol,2008,28(7):1385-1391.
6. Tao L,Gao E,Jiao X,et al.Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress[J].Circulation,2007,115(11):1408-1416.
7. 车贤达,钱琳艳,高瑞兰.麝香保心丸预防冠心病PCI术后再狭窄的临床疗效观察[J].中华中医药学刊,2008,26(4):765-766.
8. 梁铁军,赵小茜,王爱武,等.麝香保心丸治疗心律失常238例疗效分析[J].山东医药,2004,44(23):24-25.

Previous Article
替吉奥联合奥沙利铂治疗晚期结直肠癌的临床观察
Next Article
成都地区常见过敏原致敏情况研究

West China Medical Journal

麝香保心丸治疗老年慢性充血性心力衰竭的疗效观察

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content